Nabsys Opens a Distribution Channel for the OhmX™ Platform in Canada
PROVIDENCE, R.I., March 7, 2024 /PRNewswire/ -- Next generation genomic tools company, Nabsys®, has executed a nonexclusive agreement with Canadian distributor, DMark Biosciences ("DMark"), for sales of its OhmX™ platform.
- PROVIDENCE, R.I., March 7, 2024 /PRNewswire/ -- Next generation genomic tools company, Nabsys®, has executed a nonexclusive agreement with Canadian distributor, DMark Biosciences ("DMark"), for sales of its OhmX™ platform.
- OhmX is Nabsys' first commercially available product and was released in October 2023.
- DMark will be responsible for distributing both the Nabsys OhmX™ Analyzer and consumables into both public and private research core labs and institutions in the Canadian market.
- "With growing demand for the OhmX platform in the US, this distribution agreement marks an important step towards establishing a strong global distribution network," Nabsys' Chief Commercial Officer, Justin Bingham, remarked.